Tower Research Capital LLC (Trc) Exagen Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Exagen Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,312 shares of XGN stock, worth $7,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,312
Previous 6,303
79.18%
Holding current value
$7,242
Previous $11,000
63.64%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.41MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$8.35 Million0.07% of portfolio
-
Cowen And Company, LLC891KShares$4.92 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY541KShares$2.99 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$2.95 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.71 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $89.8M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...